Nutraceutical in Cardiovascular Primary Prevention
NCT03216811
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
52
Enrollment
OTHER
Sponsor class
Conditions
Hypercholesterolemia
Interventions
DRUG:
nutraceutical
Sponsor
University Hospital of Ferrara